← 返回专利悬崖列表
阿托吉泮
Tier C · 观察 / 贸易Atogepant
Merck & Co Inc
原研
2021
首批上市
-
到期年(公开口径)
无销量数据
峰值销售
化学药
类型
靶点:CGRPR
商品名:Aquipta、QULIPTA、Qulipta
适应症(已批准):偏头痛
各地区研发/上市状态
美国
批准上市
2021-09-28
欧盟
批准上市
2023-08-11
中国
申请上市
2026-01-08
日本
批准上市
2026-02-19
合成路线与中间体7 routes
原研路线 × 2优化路线(非专利)× 5工艺路线 × 0
路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。
原研Route 1步骤 8 · 总收率 5.4 g
MK-8031-001114152-23-7MK-8031-002—MK-8031-0031305324-34-8MK-8031-0041456803-29-4MK-8031-005—MK-8031-0061456803-42-1MK-8031-007—MK-8031-0086226-25-1MK-8031-0091375471-12-7MK-8031-0101375794-72-1MK-8031-0111375541-21-1API · 阿托吉泮
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| MK-8031-001 | 114152-23-7在售 | 2-(2,3,6-trifluorophenyl)acetic acid |
| MK-8031-002 | - | N-methoxy-N-methyl-2-(2,3,6-trifluorophenyl)acetamide |
| MK-8031-003 | 1305324-34-8在售 | 1-(2,3,6-trifluorophenyl)propan-2-one |
| MK-8031-004 | 1456803-29-4在售 | isopropyl N-(tert-butoxycarbonyl)-O-(methylsulfonyl)serinate |
| MK-8031-005 | - | tert-butyl 2-((tert-butoxycarbonyl)amino)-5-oxo-4-(2,3,6-trifluorophenyl)hexanoate |
| MK-8031-006 | 1456803-42-1在售 | tert-butyl ((5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate |
| MK-8031-007 | - | tert-butyl ((3S,5S,6R)-6-methyl-2-oxo-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate |
| MK-8031-008 | 6226-25-1在售 | 2,2,2-trifluoroethyl trifluoromethanesulfonate |
| MK-8031-009 | 1375471-12-7在售 | tert-butyl ((5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate |
| MK-8031-010 | 1375794-72-1在售 | (3S,5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-aminium acetyl-L-phenylalaninate |
| MK-8031-011 | 1375541-21-1在售 | (S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid |
原研Route 7步骤 3 · 总收率 5.40 g
MK-8031-055367-23-7MK-8031-0561456803-49-8MK-8031-0571456803-50-1API · 阿托吉泮
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| MK-8031-055 | 367-23-7在售 | 1,2,4-trifluorobenzene |
| MK-8031-056 | 1456803-49-8在售 | 3-hydroxy-3-(2,3,6-trifluorophenyl)butan-2-one |
| MK-8031-057 | 1456803-50-1在售 | 3-(2,3,6-trifluorophenyl)but-3-en-2-one |
优化Route 2步骤 8 · 总收率 /
MK-8031-01254923-31-8MK-8031-0136226-25-1MK-8031-0141375471-02-5MK-8031-015247564-71-2MK-8031-016—MK-8031-017—MK-8031-0181375471-11-6MK-8031-0191375471-12-7API · 阿托吉泮
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| MK-8031-012 | 54923-31-8在售 | 5-bromo-6-methylpyridin-2(1H)-one |
| MK-8031-013 | 6226-25-1在售 | 2,2,2-trifluoroethyl trifluoromethanesulfonate |
| MK-8031-014 | 1375471-02-5在售 | 5-bromo-6-methyl-1-(2,2,2-trifluoroethyl)pyridin-2(1H)-one |
| MK-8031-015 | 247564-71-2在售 | (2,3,6-trifluorophenyl)boronic acid |
| MK-8031-016 | - | 6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)pyridin-2(1H)-one |
| MK-8031-017 | - | (5S,6R)-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one |
| MK-8031-018 | 1375471-11-6在售 | (5S,6R)-3-azido-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one |
| MK-8031-019 | 1375471-12-7在售 | tert-butyl ((5S,6R)-6-methyl-2-oxo-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-3-yl)carbamate |
优化Route 3步骤 11 · 总收率 /
MK-8031-020271-63-6MK-8031-021879132-46-4MK-8031-022879132-47-5MK-8031-023879132-48-6MK-8031-02452011-50-4MK-8031-025957122-45-1MK-8031-02614150-94-8MK-8031-027957122-46-2MK-8031-028957122-47-3MK-8031-029957122-44-0MK-8031-0301059186-43-4MK-8031-0311189570-15-7MK-8031-0321375541-24-4API · 阿托吉泮
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| MK-8031-020 | 271-63-6在售 | 1H-pyrrolo[2,3-b]pyridine |
| MK-8031-021 | 879132-46-4在售 | 1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine |
| MK-8031-022 | 879132-47-5在售 | 3,3-dibromo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one |
| MK-8031-023 | 879132-48-6在售 | 1-((2-(trimethylsilyl)ethoxy)methyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one |
| MK-8031-024 | 52011-50-4在售 | 1,4-dibromobutan-2-one |
| MK-8031-025 | 957122-45-1在售 | 1'-((2-(trimethylsilyl)ethoxy)methyl)spiro[cyclopentane-1,3'-pyrrolo[2,3-b]pyridine]-2',3(1'H)-dione |
| MK-8031-026 | 14150-94-8在售 | 1-methyl-3,5-dinitropyridin-2(1H)-one |
| MK-8031-027 | 957122-46-2在售 | 3-nitro-1'-((2-(trimethylsilyl)ethoxy)methyl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one |
| MK-8031-028 | 957122-47-3在售 | 3-amino-1'-((2-(trimethylsilyl)ethoxy)methyl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one |
| MK-8031-029 | 957122-44-0在售 | 3-amino-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one |
| MK-8031-030 | 1059186-43-4在售 | (R)-3-amino-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one |
| MK-8031-031 | 1189570-15-7在售 | (R)-3-iodo-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one |
| MK-8031-032 | 1375541-24-4在售 | methyl (R)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylate |
优化Route 4步骤 5 · 总收率 /
MK-8031-03389-00-9MK-8031-03498555-51-2MK-8031-0351356330-71-6MK-8031-0361318253-26-7MK-8031-0371375542-65-6API · 阿托吉泮
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| MK-8031-033 | 89-00-9在售 | pyridine-2,3-dicarboxylic acid |
| MK-8031-034 | 98555-51-2在售 | dimethyl 5-bromopyridine-2,3-dicarboxylate |
| MK-8031-035 | 1356330-71-6在售 | (5-bromopyridine-2,3-diyl)dimethanol hydrochloride |
| MK-8031-036 | 1318253-26-7在售 | 3-bromo-1'-((2-(trimethylsilyl)ethoxy)methyl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one |
| MK-8031-037 | 1375542-65-6在售 | methyl (S)-2'-oxo-1'-((2-(trimethylsilyl)ethoxy)methyl)-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylate |
优化Route 5步骤 9 · 总收率 3.1 g
MK-8031-038137628-17-2MK-8031-0391227585-65-0MK-8031-0401455358-05-1MK-8031-0411455358-06-1MK-8031-042—MK-8031-0431455358-11-8MK-8031-0441455358-12-9MK-8031-045—MK-8031-0461455358-14-1MK-8031-0471455358-16-3MK-8031-048—MK-8031-04919614-12-1API · 阿托吉泮
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| MK-8031-038 | 137628-17-2在售 | 2,3-dibromo-5-chloropyridine |
| MK-8031-039 | 1227585-65-0在售 | (2-bromo-5-chloropyridin-3-yl)methanol |
| MK-8031-040 | 1455358-05-1在售 | 5-chloro-3-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)picolinaldehyde |
| MK-8031-041 | 1455358-06-1在售 | 1-(tert-butyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one |
| MK-8031-042 | - | (E)-1-(tert-butyl)-3-((5-chloro-3-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)pyridin-2-yl)methylene)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one |
| MK-8031-043 | 1455358-11-8在售 | 1-(tert-butyl)-3-((5-chloro-3-(hydroxymethyl)pyridin-2-yl)methyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one |
| MK-8031-044 | 1455358-12-9在售 | 1-(tert-butyl)-3-((5-chloro-3-(chloromethyl)pyridin-2-yl)methyl)-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one |
| MK-8031-045 | - | (1S,2R,4S,5R)-1-(2-bromo-5-methoxybenzyl)-2-((S)-(1-(2-bromo-5-methoxybenzyl)-6-methylquinolin-1-ium-4-yl)(hydroxy)methyl)-5-vinylquinuclidin-1-ium |
| MK-8031-046 | 1455358-14-1在售 | (S)-1'-(tert-butyl)-3-chloro-5,7-dihydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2'(1'H)-one |
| MK-8031-047 | 1455358-16-3在售 | (S)-1'-(tert-butyl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid |
| MK-8031-048 | - | (S)-(6-methylquinolin-4-yl)((1S,2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol |
| MK-8031-049 | 19614-12-1在售 | 1-bromo-2-(bromomethyl)-4-methoxybenzene |
优化Route 6步骤 5 · 总收率 3.75 g
MK-8031-050—MK-8031-051—MK-8031-052—MK-8031-0531455358-36-7MK-8031-054—API · 阿托吉泮
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| MK-8031-050 | - | 2-bromo-5-chloro-3-(((triisopropylsilyl)oxy)methyl)pyridine |
| MK-8031-051 | - | methyl 5-chloro-3-(((triisopropylsilyl)oxy)methyl)picolinate |
| MK-8031-052 | - | 5-chloro-2-(chloromethyl)-3-(((triisopropylsilyl)oxy)methyl)pyridine |
| MK-8031-053 | 1455358-36-7在售 | methyl 1-(tert-butyl)-2-oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate |
| MK-8031-054 | - | methyl 1-(tert-butyl)-3-((5-chloro-3-((triisopropylsilyl)oxy)pyridin-2-yl)methyl)-2-oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-3-carboxylate |
常见问题(FAQ)
阿托吉泮的适应症有哪些?
已批准的适应症包括:偏头痛。
阿托吉泮的专利什么时候到期?
阿托吉泮的专利到期年暂无公开口径,本页会在数据管道核实后更新。
阿托吉泮有几条合成路线?
本站收录 7 条合成路线,最短路线 3 步、总收率 5.40 g。每条路线的中间体均带登记编号与 CAS 号。
阿托吉泮的关键中间体在哪里可以采购?
阿托吉泮的多条路线中间体已挂接 CAS 档案,其中 43 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。
如何获取阿托吉泮中间体的报价?
在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。
数据来源:多源数据交叉核实(仅结构化字段) · 2026-09-27